Dipen J. Parekh
Dipen J. Parekh is a urologic oncologist whose research brings robotic surgery and AI into cancer care. He trained in India and the United States, then joined the University of Miami as chair of urology in 2012 and moved through health system leadership roles. He led the RAZOR trial, published in The Lancet in 2018, and described AI use for prostate biopsies and kidney access at the Desai Sethi Urology Institute. Since June 2025, he is CEO of UHealth and executive vice president for health affairs at the University of Miami.
Timeline
-
1990
Medical degree in India
A urologic oncologist, he earns his M.D. from the University of Poona in 1990.
-
1995–2006
Postgraduate and US training
He completes postgraduate training in general surgery at the University of Mumbai in 1995 and urology there in 1998. He then completes a urology residency at Vanderbilt University Medical Center in 2004 and a urologic-oncology fellowship at Memorial Sloan Kettering Cancer Center in 2006.
-
2011–2025
A grant and Miami leadership
In 2011, he receives a five-year, $3.1 million National Cancer Institute grant for a 14-institution trial comparing robotic and open bladder-cancer surgery. He completes an M.S. in healthcare administration at Trinity University and joins the University of Miami as chair of the Department of Urology in 2012. He becomes UHealth chief clinical officer in 2017 and serves as its chief operating officer from 2020 to 2025.
-
2013
A Gold Cystoscope Award
The American Urological Association gives him its Gold Cystoscope Award in 2013 for establishing urologic-oncology and robotic-surgery programs and contributions to transformative research.
-
2018
The RAZOR trial
He leads the RAZOR trial, published in The Lancet in 2018; it finds robotic-assisted radical cystectomy comparable to open surgery for bladder cancer.
-
By 2025
AI for prostate biopsies
At the Desai Sethi Urology Institute, he says the team uses AI for prostate biopsies and kidney access, and augmented reality to explain genitourinary anatomy to patients.
-
2026
An endowed chair and medal
In January 2026, he becomes the inaugural Magnier Endowed Chair in Urology. In May 2026, the American Association of Genitourinary Surgeons awards him its Barringer Medal.
-
Since 2025
CEO of UHealth
In June 2025, he becomes CEO of UHealth and executive vice president for health affairs at the University of Miami. He remains CEO in September 2026.
Career
- Since 2012University of MiamiChair, Chief clinical officer
- 2000–2006Vanderbilt University
Education
- 2006Memorial Sloan Kettering Cancer CenterUrologic-oncology fellowship
- 2004Vanderbilt HealthUrology residency
- 1998University of MumbaiPostgraduate training in urology
- 1995University of MumbaiPostgraduate training in general surgery
- 1990University of PoonaM.D.
- Trinity UniversityM.S. in healthcare administration
Most-cited works
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
- Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
- A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer
- Randomized Prospective Evaluation of Extended Versus Limited Lymph Node Dissection in Patients With Clinically Localized Prostate Cancer
- Perioperative Outcomes and Oncologic Efficacy from a Pilot Prospective Randomized Clinical Trial of Open Versus Robotic Assisted Radical Cystectomy
Sources and credits
Photo: We have no published photo of Dipen J. Parekh yet. Send us a free-licensed photo.
- Dr. Dipen Parekh appointed new CEO of UHealth
- Dipen J. Parekh
- 1st randomized study compares robotic, open procedures for bladder cancer
- Dipen Parekh, M.D., Named Chief Executive Officer of University of Miami Health System
- Dipen J Parekh MD Miller School of Medicine
- AwardsArchive
- For Urologists, the Future Is Now
- Dipen J. Parekh, M.D., Honored as Inaugural Magnier Endowed Chair in Urology
- Prestige Honors Performance: UHealth CEO Dipen Parekh, M.D., Awarded Barringer Medal for Distinguished Career and Future Impact
- UHealth Named a 2026 Vizient Ambulatory Quality and Accountability Top Performer - InventUM
